Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Instructions to Authors

International journal of applied Ayurved Research (IJAAR) is a bi-monthly online journal. IJAAR provides a plot form for different sources of Ayurvedic research and revalidated knowledge in Ayurveda to all scholars, students, and practitioners. we accept Original articles, Single case reports, review articles, short notes, book reviews, and events related to the field of Ayurveda.

Authors should prepare the manuscript according to the standards of IJAAR. Manuscripts not fulfilling the general guidelines of IJAAR may result in delayed publication or rejection.

The review process and detailed instructions to Authors and Editors: Review Policy

The articles submitted will be evaluated by the Editorial team for their completeness they are assigned to the reviewers of the concerned subject the article will be evaluated for the subject content, relevance to the subject, language, and plagiarism. The journal follows a double-blind review process. After review, if any comments or suggestions are received from the reviewer, then the article is forwarded to the author for modifications. 

Once the author completes the corrections, the manuscript will be considered for publication. 

Canvassing in any form, at any stage of the article will lead to the rejection of the manuscript. 

The minimum duration of the review process from the date of submission of the article will be 7 working days. 

The article accepted for publication will be queued for the next issue of publication.

The journal does not publish articles continuously. 

http://www.icmje.org/icmje-recommendations.pdf 

Plagiarism:
Plagiarism is the act of using another person’s  same contents or ideas without giving credit to that person. The authors are strictly advised not to indulge in any form of plagiarism. If the content is found to be plagiarised submitted manuscript will be rejected

Page limitations for Manuscript:
Original research articles should not exceed 6 pages
Short notes up to 3 pages
Review articles should not exceed 8 pages

General guidelines:
The manuscript should be neatly typed with a single space in between the sentence including the tables without any grammatical mistakes and spelling mistakes. All Ayurvedic terms are to be made italics and the relevant English meaning of the Ayurvedic terms  where the first time appears should be given in the bracket 
Prepare the manuscript in A4 size with at least 2.54 cm margins on all sides, and quote the page number serially.
The whole manuscript should prepare in Times New Roman with a font size of 12. The title shall be in font size 14 bolded with all capitals.

Name the main author's surname first (first name middle name) with the highest educational qualification /designation/ institute name /hospital name/etc, E-mail id, phone number/ country.
Details of the corresponding author should be mentioned separately.

Subtitles should be in font size 12 Bold Capitals. Subheadings shall be 12 font bold lowercase. Botanical name / Latin name/Ayurvedic terms should be in Italics. Every Article to be subjected to plagiarism software 

Arrange the manuscript in the following order

Title: The title should describe in brief the contents of the article.

Author names: Authors' names should be mentioned below the title with the Designation of the authors with full contact details like address, phone number, and email should be mentioned.

Abstract:

keywords:

Introduction:
Materials and methods:
Observations and Results:
Discussion:
Conclusion:
Acknowledgment:
References:

Original Research Articles:
Original articles include Randomized clinical controlled trials, surveys, Drug trials, Single case studies, screening of cases, and Diagnostic studies.

Abstract:

All abstracts must be organized into a structured format appropriate to the type of article using the headings listed in the following table:
 
Primary Research Literature Reviews Case Reports
Aim Aim Aim
Materials & Methods Background Background
Results Review Results Case Description
Conclusion Conclusion Conclusion
Clinical Significance Clinical Significance Clinical Significance

The abstract should not exceed more than 250 words.No hyperlinks for references cited in the Abstract.

Keywords: Six important keywords should be mentioned for the purpose of indexing (Preferably with the terms which are not mentioned in the title and required for search).

1) What's already known about this topic?

2) What does this study add? write in short 

3) Ethics committee approval letter is mandatory for all original research articles. 

Conflicts of Interest of each author/ contributor. A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an author's form

Introduction: The introduction should be concise it should include the background of the subject, earlier works carried out and the relationship and significance of this work, and the aims and objectives of this study, and identify what issues are going to be addressed

Materials and methods:
Write complete details of the study design, inclusive, exclusive criteria, a drug used & route of administration of the drug Commercially produced materials, devices, software, etc. must be followed by name of manufacturer and location. Experiments on humans are to be approved/clearance by the (Institutional/regional/National)Ethical committee with obtained informed consent from all research participants in accordance with the Declaration of Helsinki by mentioning the experimental participants in the study. In the case of Animal experiments approved by the ministry of social justice and Empowerment, the Government of India and OECD notified guidelines should be followed strictly. Informed consent has been obtained it should be indicated in the published article. Involving the participation of minors (e.g., consent from legal guardians) and conducting clinical trials Informed consent has been obtained it should be indicated in the manuscript. Statistical methods should be clearly specified. 

Observations and Results: Mention important observations found during the study if required represent in the form of graphs, tables, figures, and good-quality visual documents.

Tables

1. Tables should be self-explanatory and should not duplicate textual material.

2. Tables with more than 10 columns and 25 rows are not acceptable.

3. Number tables, in Arabic numerals, consecutively in the order of their first citation in the text and supply a brief title for each.

Illustrations (Figures)

1. Upload the images in JPEG format. The file size should be within 4 MB in size while uploading.

2. Figures should be numbered consecutively according to the order in which they have been first cited in the text.

3. Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column.

4. Symbols, arrows, or letters used in photomicrographs should contrast with the background and should be marked neatly with transfer type or by tissue overlay and not by pen.

5. Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.

6. When graphs, scatter-grams, or histograms are submitted the numerical data on which they are based should also be supplied.

7. The photographs and figures should be trimmed to remove all the unwanted areas.

8. If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph.

9. If a figure has been published elsewhere, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. A credit line should appear in the legend for such figures.

Discussion: The discussion should focus on the new and important findings of the study. The observations should be related to other relevant studies in a logical sequence. It should summarize, but not repeat the Results. The Discussion should end with a summary of the data and conclusions. The conclusions should be linked with the aims and objectives of the study and should clearly state whether the objective was achieved. Limitations of the study should also be mentioned. if any adverse effects of the drug can also be discussed.

Conclusion: The conclusion should be concise with a clear explanation
References: Cite the references as per the international standards for publication/Vancouver style.

Examples of classical References:

  1. Acharya YT, editor. Commentary Nibandha Sangraha of Dalhanacharya on Sushruta Samhita of Sushruta, Sutra Sthana. Ch. 38., Ver. 71. Varanasi: Chaukhambha Surbharti Publisher; 2018. p. 189.
  2. Kashinnath P, Gorakhnath C, editors. Hindi Commentary of Vidyotini on Charaka Samhita of Agnivesha, Siddhi Sthana. Ch. 2., Ver. 13. Varanasi: Cukhambha Sanskrit Series Office; 2013. p. 981

Case Report:

Title 1 The words “Case report” should be in the title along with the area of focus.

Keywords: 5 to 6 keywords that identify areas covered in this case report. 

Abstract

3a Introduction—What is unique about this case? What does it add to the medical literature? 

3b The main symptoms of the patient and the important clinical findings. 

3c The main diagnoses, therapeutic interventions, and outcomes.

3d Conclusion—What are the main “take-away” lessons from this case? 

Introduction

4 One or two paragraphs summarizing why this case is unique with references. 

Patient Information

5a De-identified demographic information and other patient-specific information. 

5b Main concerns and symptoms of the patient. 

5c Medical, family, and psychosocial history including relevant genetic information (also see timeline). 

5d Relevant past interventions and their outcomes. 

Clinical Findings

6 Describe the relevant physical examination (PE) and other significant clinical findings. 

Timeline

7 Important information from the patient’s history organized as a timeline. 

Diagnostic

Assessment

8a Diagnostic methods (such as PE, laboratory testing, imaging, surveys). 

8b Diagnostic challenges (such as access, financial, or cultural). 

8c Diagnostic reasoning including other diagnoses considered. 

8d Prognostic characteristics (such as staging in oncology) where applicable.

Therapeutic

Intervention

9a Types of intervention (such as pharmacologic, surgical, preventive, self-care). 

9b Administration of intervention (such as dosage, strength, duration). 

9c Changes in the intervention (with rationale). 

Follow-up and Outcomes

10a Clinician and patient-assessed outcomes (when appropriate). 

10b Important follow-up diagnostic and other test results. 

10c Intervention adherence and tolerability (How was this assessed?). 

10d Adverse and unanticipated events. 

Discussion:

11a Discussion of the strengths and limitations of your approach to this case.

11b Discussion of the relevant medical literature. 

11c The rationale for conclusions (including assessment of possible causes). 

11d The primary “take-away” lessons of this case report.

Patient Perspective:

12 When appropriate the patient should share their perspective on the treatments they received. 

Informed Consent: Informed consent is mandatory to involve in a clinical study and needs to specify in the manuscript. Involving the participation of minors (e.g., consent from legal guardians) and conducting clinical trials Informed consent has been obtained it should be indicated in the manuscript.

13 Did the patient give informed consent? Please provide it if requested.  Yes No

Interesting and new cases can be reported providing great therapeutic effect, including specific diagnostic criteria help full to the students and researchers these should be included an abstract, keywords introduction, case report, discussion, and references.
Review Articles: It is expected that these articles would be written by individuals who have done on the subject related to fundamental principles, diseases, and drugs. A short summary of the work done by the contributor in the field of Ayurveda. These methods should be summarized in the abstract.

Conflict of interest

All authors are requested to disclose any actual or potential conflict of interest including any financial, personal, or other relationships with other people or organizations that could inappropriately influence, or be perceived to influence, their work.

Publication frequency: 

International journal of applied Ayurveda Research (IJAAR) publishes 6 issues in a year in the following months:

January - February issue in the month of March. 

March - April issue in the month of May. 

May - June issue in the month of July.

July - August issue in the month of September. 

September - October issue in the month of November.

November - December issue in the month of January.

Publication charges: The charge for publication of the journal includes web maintenance for Reviewers.  Rs. 1500/- INR The authors have to pay the amount after complete acceptance of their manuscript before the publication the Editor in Chief is communicated with regarding the processing Fee and mode of payment.

Note: The Editor in Chief reserves the right to make alterations in the manuscripts which do not meet the scientific standard of IJAAR and with repetitive mistakes.

This work is licensed under a Creative Commons Attribution 4.0 International License.

Privacy Statement:

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Research Articles

Section default policy

Copyright Notice

  1. I/We certify that I/we have participated sufficiently in the intellectual content, conception and design of this work or the analysis and interpretation of the data (when applicable), as well as the writing of the manuscript, to take public responsibility for it and have agreed to have my/our name listed as a contributor of this work.
  2. I/We are the sole authors of the Article and maintain the authority to enter into this Agreement and granting rights to IJAAR does not infringe any clause of this agreement. 
  3. Each author confirms they meet the criteria for authorship as established by the ICMJE.
  4. No one who has contributed significantly to the work has been denied authorship and those who helped in this work have been duly acknowledged and all the sources of outside support of the project are mentioned.
  5. I/We have read instructions to authors; I/we believe the manuscript represents valid work.
  6. The article does not contravene, any unlawful contents, defamatory, or which would, if published, in any way whatsoever, no part of this manuscript has been copied exactly from any other source, neither this manuscript nor one with substantially similar content under my/our authorship has been published or is being considered for publication elsewhere.
  7. I/We attest that I/we shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested. I am/We are the author(s) are fully responsible, if this manuscript contains any such type fabrication, fraud, or plagiarism.
  8. Permission to reproduce tables and figure has been obtained and submitted (If any).
  9. If any objections or complaints regarding the above titled article, Chief Editor have full rights to modify or delete whole or part of the written content even after publication also.
  10. Financial interests, direct or indirect, that exist or may be perceived to exist for individual contributors in connection with the content of this paper have been disclosed in the cover letter.
  11. I/We do not have any conflict of interest (financial/other) other than those declared.
  12. I/We have reviewed final version of this manuscript and approved for the publication in the IJAAR.
  13. We give the rights to the corresponding author to make necessary changes as per the request of the journal, do the rest of the correspondence on our behalf and he/she will act as the guarantor for the manuscript on our behalf.
  14. I/We hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership, including any and all rights incidental thereto, exclusively to the IJAAR, in the event that this work is published by the Journal.
  15. This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. By this transfer, the article becomes the property of the IJAAR and may not be published elsewhere without written permission from the IJAAR.
  16. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAAR.
  17. No responsibility is assumed by IJAAR, its staff or members of the editorial board for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in a publication by IJAAR.
  18. The IJAAR, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAAR, subject to the express conditions that (a) the author notify IJAAR in advance in writing of this republication and (b) a credit line attributes the original publication to IJAAR
  19. Neither the IJAAR nor its publishers nor anyone else involved in creating, producing or delivering the IJAAR (International Journal of Applied Ayurved Research) or the materials contained therein, assumes any liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the IJAAR, nor shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of the IJAAR.
  20. The IJAAR (International Journal of Applied Ayurved Research) and its publishers make no representations or warranties with respect to any treatment, action, or application of medication or preparation by any person following the information offered or provided within or through the IJAAR. The IJAAR and its publishers will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising there from.
  21. No addition, deletion or change in the sequence of authors is allowed at a later stage without valid reasons.
  22. If the authorship is contested before publication the manuscript will be either returned or kept in abeyance till the issue is resolved.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.